M&A / Property
DiagnaMed Enters Acquisition Agreement to Acquire Colchester East Natural Hydrogen Project in Nova Scotia

DMED · Price
Executive Summary
- DiagnaMed Holdings entered into an Acquisition Agreement to acquire the Colchester East Natural Hydrogen Project (30 licences, 2,104 claims) in Nova Scotia.
- The deal includes a $10,000 cash payment, issuance of 10 million common shares, and a 2.0% royalty to sellers (with optional repurchase of 50% for $2 M).
- Concurrently, Fabrice Consalvo was appointed to the Board of Directors, bringing extensive energy‑sector experience.
Key Details
- Acquisition Target: Colchester East Natural Hydrogen Project, Nova Scotia – 30 licences covering 2,104 claims.
- Strategic Rationale: Positions DiagnaMed within Canada’s most active natural hydrogen corridor alongside major players (Koloma, Rio Tinto, QIMC) and complements existing Ontario Temiscamingue holdings.
- Acquisition Terms:
- Non‑refundable cash payment of $10,000.
- Issuance of 10,000,000 common shares to the sellers.
- Sellers retain a 2.0 % royalty on hydrogen or mineral revenues.
- DiagnaMed may repurchase 50 % of the royalty for $2,000,000.
- Regulatory Conditions: Transaction subject to CSE approval; all issued securities subject to a statutory four‑month‑and‑one‑day hold period. Sellers are arm’s‑length.
- Board Appointment: Fabrice Consalvo joins DiagnaMed’s Board of Directors; brings >30 years global energy experience (Areva, Accenture, Investissement Québec) and currently leads Gamanergie Consulting.
- CEO Comment: John Karagiannidis highlighted the acquisition as a “strategic opportunity” that places DiagnaMed among the largest natural hydrogen claim holders in Canada and aligns with its technology deployment goals.
Notable Quotes
“This acquisition represents a strategic opportunity and positions DiagnaMed among the largest natural hydrogen claim holders in Canada… our entry into this district is timely, deliberate, and aligned with our goal of deploying cutting‑edge extraction technologies across multiple high‑potential jurisdictions.” – John Karagiannidis, President & CEO
Materiality Assessment: Material – Positive (significant expansion of asset base and strategic positioning in a high‑growth sector).
More from Diagnamed Holdings Corp.
May 15, 2026 · 07:31